SCHRÖDINGER, INC.

(SDGR)
  Report
Delayed Nasdaq  -  05/20 04:00:00 pm EDT
24.75 USD   +0.12%
05/19SCHRODINGER, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
05/19Schrödinger Announces Appointment of Arun Oberoi to Board of Directors
BU
05/19Schrödinger, Inc. Appoints of Arun Oberoi to Board of Directors
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about SCHRÖDINGER, INC.
05/19Schrödinger Announces Appointment of Arun Oberoi to Board of Directors
BU
05/19Schrödinger, Inc. Appoints of Arun Oberoi to Board of Directors
CI
05/18TRANSCRIPT : Schrödinger, Inc. Presents at Citi Biopharma VIRTUAL Co-Panel Day, May-18-202..
CI
05/13Schrödinger to Present at Citi Biotech Virtual Co-Panel Day
BU
05/04Schrödinger to Seek Acquisitions
CI
05/04TRANSCRIPT : Schrödinger, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04Earnings Flash (SDGR) SCHRODINGER Reports Q1 Revenue $48.7M, vs. Street Est of $34.6M
MT
05/04Schrödinger Reports First Quarter 2022 Financial Results
BU
05/04Schrödinger, Inc. Provides Revenue Guidance for the Fiscal Year Ending December 31, 202..
CI
05/04Schrödinger, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/20Schrödinger to Announce First Quarter 2022 Financial Results on May 4
BU
04/19Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BU
04/12Schrödinger Reports New Preclinical Data Supporting Advancement of Its Wee1 Inhibitor P..
BU
04/12Schrödinger, Inc. Reports New Preclinical Data Supporting Advancement of Its Wee1 Inhib..
CI
03/17Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BU
More most relevant news
All news about SCHRÖDINGER, INC.
05/19SCHRODINGER, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
05/19Schrödinger Announces Appointment of Arun Oberoi to Board of Directors
BU
05/19Schrödinger, Inc. Appoints of Arun Oberoi to Board of Directors
CI
05/18TRANSCRIPT : Schrödinger, Inc. Presents at Citi Biopharma VIRTUAL Co-Panel Day, May-18-202..
CI
05/13Schrödinger to Present at Citi Biotech Virtual Co-Panel Day
BU
05/04Schrödinger to Seek Acquisitions
CI
05/04TRANSCRIPT : Schrödinger, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04SCHRODINGER, INC. Management's Discussion and Analysis of Financial Condition and Resu..
AQ
05/04Earnings Flash (SDGR) SCHRODINGER Reports Q1 Revenue $48.7M, vs. Street Est of $34.6M
MT
05/04Schrödinger Reports First Quarter 2022 Financial Results
BU
More news
News in other languages on SCHRÖDINGER, INC.
05/19Schrödinger, Inc. nomme Arun Oberoi au conseil d'administration
05/04Schrödinger cherche à faire des acquisitions
05/04Earnings Flash (SDGR) SCHRODINGER annonce un chiffre d'affaires de 48,7 millions de dol..
05/04Schrödinger, Inc. fournit des prévisions de revenus pour l'année fiscale se terminant l..
05/04Schrödinger, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
04/12Schrödinger, Inc. rapporte de nouvelles données précliniques soutenant l'avancement de ..
03/01Les actions de Schrodinger augmentent après que Citigroup a commencé à les couvrir à l'..
02/25MISE À JOUR SECTORIELLE : Les actions du secteur de la santé en hausse, les secteurs défen..
02/25MISE À JOUR SECTORIELLE : Les actions du secteur de la santé contribuent à la reprise des ..
02/25MISE À JOUR SECTORIELLE : Soins de santé
More news
Analyst Recommendations on SCHRÖDINGER, INC.
03/01Citigroup Initiates Schrodinger at Buy With $55 Price Target
MT
02/28Berenberg Bank Adjusts Schrodinger's Price Target to $88 From $89, Maintains Buy Rating
MT
02/25Piper Sandler Adjusts Schrodinger's Price Target to $84 From $87, Reiterates Overweight..
MT
2021Morgan Stanley Lowers Schrodinger to Equal-Weight From Overweight, Price Target to $49 ..
MT
2021Piper Sandler Initiates Schrodinger With Overweight Rating, $87 Price Target
MT
More recommendations
Press releases
05/19SCHRODINGER, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
05/19Schrödinger Announces Appointment of Arun Oberoi to Board of Directors
BU
05/13Schrödinger to Present at Citi Biotech Virtual Co-Panel Day
BU
05/04SCHRODINGER, INC. Management's Discussion and Analysis of Financial Condition and Resu..
AQ
05/04Schrödinger Reports First Quarter 2022 Financial Results
BU
More press releases
Upcoming event on SCHRÖDINGER, INC.